Hyperfine Investor Presentation Deck
Forward-looking Statements
This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995. Actual results of Hyperfine, Inc. (the "Company") may differ from its expectations, estimates and projections and consequently, you should not rely on
these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend,"
"plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or
expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's goals and
commercial plans, the benefits of the Company's products and services, and the Company's future performance and its ability to implement its strategy. These
for ard-looking statements involve significant risks and uncertainties that could cause the act results to differ materially from the expected results. Most of
these factors are outside of the Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the success,
cost and timing of the Company's product development and commercialization activities, including the degree that the Swoop® system is accepted and used by
healthcare professionals; the impact of COVID-19 on the Company's business; the inability to maintain the listing of the Company's Class A common stock on
the Nasdaq; the Company's inability to grow and manage growth profitably and retain its key employees; changes in applicable laws or regulations; the inability
of the Company to raise financing in the future; the inability of the Company to obtain and maintain regulatory clearance or approval for its products, and any
related restrictions and limitations of any cleared or approved product; the inability of the Company to identify, in-license or acquire additional technology; the
inability of the Company to maintain its existing or future license, manufacturing, supply and distribution agreements and to obtain adequate supply of its
products; the inability of the Company to compete with other companies currently marketing or engaged in the development of products and services that the
Company is currently marketing or developing; the size and growth potential of the markets for the Company's products and services, and its ability to serve
those markets, either alone or in partnership with others; the pricing of the Company's products and services and reimbursement for medical procedures
conducted using the Company's products and services; the Company's estimates regarding expenses, revenue, capital requirements and needs for additional
financing; the Company's financial performance; and other risks and uncertainties indicated from time to time in Company's filings with the Securities and
Exchange Commission, including those under "Risk Factors" therein. The Company cautions readers that the foregoing list of factors is not exclusive and that
readers should not place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or
accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or
any change in events, conditions or circumstances on which any such statement is based.
2
PROPERTY OF HYPERFINE, INC. ©2023. All rights reserved.
HYPERFINEⓇView entire presentation